Nora Pällmann

427 total citations
10 papers, 299 citations indexed

About

Nora Pällmann is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Nora Pällmann has authored 10 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Hematology and 2 papers in Cell Biology. Recurrent topics in Nora Pällmann's work include Polyamine Metabolism and Applications (4 papers), Epigenetics and DNA Methylation (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Nora Pällmann is often cited by papers focused on Polyamine Metabolism and Applications (4 papers), Epigenetics and DNA Methylation (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Nora Pällmann collaborates with scholars based in Germany, Switzerland and Norway. Nora Pällmann's co-authors include Stefan Balabanov, Melanie Braig, Carsten Bokemeyer, Henning Sievert, Joachim Hauber, Christian Hagel, Ladan Fazli, Fahri Saatcioglu, Paul S. Rennie and Håvard E. Danielsen and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Nora Pällmann

10 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nora Pällmann Germany 8 237 54 36 35 32 10 299
Rahmen Bin Ali Netherlands 8 281 1.2× 26 0.5× 40 1.1× 61 1.7× 14 0.4× 9 404
Marije Havermans Netherlands 10 353 1.5× 57 1.1× 66 1.8× 47 1.3× 14 0.4× 17 489
Armando Reyes‐Palomares Spain 9 211 0.9× 23 0.4× 49 1.4× 41 1.2× 8 0.3× 22 287
Brian M. Ortmann United Kingdom 10 236 1.0× 27 0.5× 31 0.9× 195 5.6× 32 1.0× 15 372
Dilki Wickramarachchi United States 8 232 1.0× 30 0.6× 61 1.7× 23 0.7× 50 1.6× 11 343
Christelle Dubey Switzerland 5 313 1.3× 17 0.3× 48 1.3× 53 1.5× 57 1.8× 10 428
Sangeetha Narasimhan United Arab Emirates 10 178 0.8× 29 0.5× 21 0.6× 25 0.7× 15 0.5× 29 316
Edwin C.J.M. de Vet Netherlands 10 304 1.3× 70 1.3× 52 1.4× 45 1.3× 19 0.6× 12 383
Wenjia Lou United States 12 299 1.3× 23 0.4× 21 0.6× 56 1.6× 15 0.5× 16 355
Yelena Chernyavskaya United States 9 403 1.7× 12 0.2× 53 1.5× 119 3.4× 50 1.6× 12 510

Countries citing papers authored by Nora Pällmann

Since Specialization
Citations

This map shows the geographic impact of Nora Pällmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Pällmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Pällmann more than expected).

Fields of papers citing papers by Nora Pällmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Pällmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Pällmann. The network helps show where Nora Pällmann may publish in the future.

Co-authorship network of co-authors of Nora Pällmann

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Pällmann. A scholar is included among the top collaborators of Nora Pällmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Pällmann. Nora Pällmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Deng, Ke, Nora Pällmann, Wanja Kildal, et al.. (2025). Endoplasmic reticulum stress-driven nucleotide catabolism fuels prostate cancer. Cancer Letters. 630. 217888–217888. 1 indexed citations
2.
Pällmann, Nora, Ke Deng, Martina Tesikova, et al.. (2021). Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease Progression. Cancer Research. 81(15). 4066–4078. 18 indexed citations
3.
Pällmann, Nora, Martina Tesikova, Hatice Zeynep Nenseth, et al.. (2019). Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer. Oncogene. 38(35). 6301–6318. 41 indexed citations
4.
Jin, Yang, Ling Wang, Su Qu, et al.. (2015). STAMP 2 increases oxidative stress and is critical for prostate cancer. EMBO Molecular Medicine. 7(3). 315–331. 49 indexed citations
5.
Pällmann, Nora, Melanie Braig, Henning Sievert, et al.. (2015). Biological Relevance and Therapeutic Potential of the Hypusine Modification System. Journal of Biological Chemistry. 290(30). 18343–18360. 41 indexed citations
6.
Sievert, Henning, Nora Pällmann, Katharine K. Miller, et al.. (2014). A novel mouse model for inhibition of DOHH mediated hypusine modification reveals crucial function for embryonic development, proliferation and oncogenic transformation. Disease Models & Mechanisms. 7(8). 963–76. 45 indexed citations
7.
Braig, Melanie, Nora Pällmann, Doris Steinemann, et al.. (2014). A ‘telomere-associated secretory phenotype’ cooperates with BCR-ABL to drive malignant proliferation of leukemic cells. Leukemia. 28(10). 2028–2039. 32 indexed citations
8.
Brümmendorf, Tim H., Nora Pällmann, Doris Steinemann, et al.. (2013). BCR-ABL Cooperates With a “Telomere-Associated Secretory Phenotype” (TASP) To Facilitate Malignant Proliferation Of Hematopoietic Stem Cells. Blood. 122(21). 3976–3976. 2 indexed citations
9.
Sievert, Henning, Simone Venz, Vishnu M. Dhople, et al.. (2012). Protein-protein-interaction Network Organization of the Hypusine Modification System. Molecular & Cellular Proteomics. 11(11). 1289–1305. 15 indexed citations
10.
Hagel, Christian, Alexander Schulte, Kristoffer Weber, et al.. (2012). Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies. PLoS ONE. 7(8). e43468–e43468. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rahmen Bin Ali Breakdown of academic impact, for papers by Marije Havermans Breakdown of academic impact, for papers by Armando Reyes‐Palomares Breakdown of academic impact, for papers by Brian M. Ortmann Breakdown of academic impact, for papers by Dilki Wickramarachchi Breakdown of academic impact, for papers by Christelle Dubey Breakdown of academic impact, for papers by Sangeetha Narasimhan Breakdown of academic impact, for papers by Edwin C.J.M. de Vet Breakdown of academic impact, for papers by Wenjia Lou Breakdown of academic impact, for papers by Yelena Chernyavskaya
Rankless by CCL
2026